Unveiling the immune microenvironment of complex tissues and tumors in transcriptomics through a deconvolution approach

被引:0
|
作者
Shu-Hwa Chen [1 ]
Bo-Yi Yu [2 ]
Wen-Yu Kuo [3 ]
Ya-Bo Lin [3 ]
Sheng-Yao Su [4 ]
Wei-Hsuan Chuang [3 ]
I.-Hsuan Lu [3 ]
Chung-Yen Lin [3 ]
机构
[1] TMU Research Center of Cancer Translational Medicine, Taipei Medical University, 250 Wu-Xing Street, Taipei
[2] Research Center for Advanced Science and Technology, the University of Tokyo, 4-6-1 Komaba, Meguro-Ku, Tokyo
[3] Institute of Information Science, Academia Sinica, 128 Academia Road, Section 2, Taipei, Nankang
[4] Department of Smart Computing and Applied Mathematics, Tunghai University, Taichung City
[5] Institute of Fisheries Science, National Taiwan University, Taipei
[6] Genome and Systems Biology Degree Program, National Taiwan University, Taipei
关键词
Alpha diversity; Beta diversity; Cancer; Deconvolution; Immune microenvironment; Immunotherapy; Precision medicine;
D O I
10.1186/s12885-025-14089-w
中图分类号
学科分类号
摘要
Accurately resolving the composition of tumor-infiltrating leukocytes is pivotal for advancing cancer immunotherapy strategies. Despite the success of some clinical trials, applying these strategies remains limited due to the challenges in deciphering the immune microenvironment. In this study, we developed a streamlined, two-step workflow to address the complexity of bioinformatics processes involved in analyzing immune cell composition from transcriptomics data. Our dockerized toolkit, DOCexpress_fastqc, integrates the hisat2-stringtie pipeline with customized scripts within Galaxy/Docker environments, facilitating RNA sequencing (RNA-seq) gene expression profiling. The output from DOCexpress_fastqc is seamlessly formatted with mySORT, a web application that employs a deconvolution algorithm to determine the immune content across 21 cell subclasses. We validated mySORT using synthetic pseudo-bulk data derived from single-cell RNA sequencing (scRNA-seq) datasets. Our predictions exhibit strong concordance with the ground-truth immune cell composition, achieving Pearson’s correlation coefficients of 0.871 in melanoma patients and 0.775 in head and neck cancer patients. Additionally, mySORT outperforms existing methods like CIBERSORT in accuracy and provides a wide range of data visualization features, such as hierarchical clustering and cell complexity plots. The toolkit and web application are freely available for the research community, providing enhanced resolution for conventional bulk RNA sequencing data and facilitating the analysis of immune microenvironment responses in immunotherapy. The mySORT demo website and Docker image are free at https://mysort.iis.sinica.edu.tw and https://hub.docker.com/r/lsbnb/mysort_2022. © The Author(s) 2025.
引用
收藏
相关论文
共 4 条
  • [1] The Immune Microenvironment Landscape of Pituitary NeuroEndocrine Tumors, a Transcriptomic Approach
    Vela-Patino, Sandra
    Salazar, Ma. Isabel
    Taniguchi-Ponciano, Keiko
    Vadillo, Eduardo
    Gomez-Apo, Erick
    Escobar-Espana, Aurea
    Perez-Koldenkova, Vadim
    Bonifaz, Laura
    Aguilar-Flores, Cristina
    Marrero-Rodriguez, Daniel
    Mercado, Moises
    GENES, 2024, 15 (05)
  • [2] Single-cell transcriptomics reveals metabolic remodeling and functional specialization in the immune microenvironment of bone tumors
    Jun Chen
    Na Cui
    Shao-Hui He
    Chun-Yan Xia
    Wei-Qing Li
    Journal of Translational Medicine, 23 (1)
  • [3] Complete deconvolution of DNA methylation signals from complex tissues: a geometric approach
    Zhang, Weiwei
    Wu, Hao
    Li, Ziyi
    BIOINFORMATICS, 2021, 37 (08) : 1052 - 1059
  • [4] Remodeling of the Tumor Microenvironment Through PAK4 Inhibition Sensitizes Tumors to Immune Checkpoint Blockade
    Abril-Rodriguez, Gabriel
    Torrejon, Davis Y.
    Karin, Daniel
    Campbell, Katie M.
    Medina, Egmidio
    Saco, Justin D.
    Galvez, Mildred
    Champhekar, Ameya S.
    Perez-Garcilazo, Ivan
    Baselga-Carretero, Ignacio
    Singh, Jas
    Comin-Anduix, Begona
    Puig-Saus, Cristina
    Ribas, Antoni
    CANCER RESEARCH COMMUNICATIONS, 2022, 2 (10): : 1214 - 1228